SENGO-CAM study is a sham-controlled simple blind trial which aim is to study the efficacy of great occipital nerve stimulation (GONS) associated with medication withdrawal in the treatment of medication overuse headache occurring in migraine patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
30
* Active Comparator: Arm Active SENGO The patients will be hospitalised and managed by medication withdrawal and active GONS, surgically temporarily implanted. * Arm sham SENGO : The patients will be hospitalised and managed by medication withdrawal and sham GONS, surgically temporarily implanted.
Neurology department - La timone
Marseille, France
Neurosurvery department
Nice, France
Headache Emergency Center
Paris, France
Neurology department - CHU Rangueil
Toulouse, France
Primary endpoint will be the comparison of the rate of headache-free patients, fourteen days after medication withdrawal, in both groups (GONS versus sham)
Time frame: 14 days
number of headache days during the 14 days withdrawal period
Time frame: 14 days
maximal intensity and duration of rebound headache
Time frame: 14 days
rescue medication used
Time frame: 14 days
withdrawal facility perceived by the patient
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.